Euphoria Infotech board approves 8 lakh preferential warrants at Rs. 29.38 each
Board approves issue of 8,00,000 warrants on preferential basis and seeks shareholder nod to raise authorised capital.
Key takeaways
- 8,00,000 warrants to be issued on preferential basis, each convertible into 1 equity share.
- Issue price set at Rs. 29.38/- per warrant / equity share, aggregating to Rs. 2,35,04,000/-.
- At least 25% of consideration payable on allotment of warrants, 75% on share allotment.
- Authorised share capital to rise from Rs. 3,25,00,000/- to Rs. 4,00,00,000/-, subject to approval.
- EOGM scheduled on December 14, 2026, Monday, at 1.00 P.M. to seek member approvals.
Key terms
- Action
- Other
- Terms
- Rs. 29.38/- per warrant
- Aggregate warrant issue size Rs. 2,35,04,000/-
- Each of two public investors may receive up to 4,00,000 warrants
Euphoria Infotech (India) Ltd has told the stock exchange that its board, at the meeting held on November 14, 2026, approved a preferential issue of warrants and an increase in authorised share capital, along with routine financial results and board changes. The filing does not announce any buyback, bonus issue or dividend, and it does not specify a record date for such actions.
According to the board's outcome letter dated November 14, 2026, the company plans to issue warrants that can be converted into equity shares, subject to shareholder approval.
Key terms
- Type of instrument: 8,00,000 (Eight Lakh) warrants, each carrying a right to subscribe to 1 (one) equity share of the Company (board's outcome letter, point 3; Annexure A, Sr. No. 1 and 3).
- Issue price: Rs. 29.38/- (Rupees Twenty-Nine and Thirty-Eight Paise Only) per warrant / equity share (board's outcome letter, point 3; Annexure A, Sr. No. 3 and III).
- Aggregate issue size: Rs. 2,35,04,000/- (Rupees Two Crore Thirty-Five Lakh Four Thousand Only) (board's outcome letter, point 3; Annexure A, Sr. No. 3).
- Payment structure: At least 25% (Twenty-Five Percent) of the consideration payable on the date of allotment of the warrants, and the balance 75% (Seventy-Five Percent) payable at the time of allotment of equity shares on exercise of the warrants (Annexure A, Sr. No. 3).
- Tenure / exercise period: Warrants may be exercised in one or more tranches during the period commencing from the date of allotment of the warrants until expiry of 18 (Eighteen) months from the date of allotment of the Warrants (Annexure A, Sr. No. 1).
- Type of issuance: Preferential allotment in accordance with the Companies Act, 2013 and Chapter V of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 (Annexure A, Sr. No. 2).
- Proposed allottees:
- Ajay Singhania – Public category – Maximum No. of Warrants to be offered: 4,00,000 (Annexure A, Sr. No. 4.I).
- Krishna Kumar Singhania – Public category – Maximum No. of Warrants to be offered: 4,00,000 (Annexure A, Sr. No. 4.I).
- Post-conversion holding (illustrative): Assuming full conversion of all warrants issued to each proposed allottee, the table in Annexure A shows 4,00,000 equity shares and 10.81% of holdings for each of Ajay Singhania and Krishna Kumar Singhania (Annexure A, Sr. No. 4.II, note *).
The issue price of Rs. 29.38/- per equity share / warrant has been computed as per Regulation 164(1) read with Regulation 166A of the SEBI ICDR Regulations, based on a valuation report dated November 14, 2026 from Mr. Manish Gadia, Registered Valuer, [Reg No. IBBI/RV/06/2019/11646] (Annexure A, Sr. No. III).
Increase in authorised share capital
The board has also approved, subject to shareholder approval, an increase in the authorised share capital of the company (board's outcome letter, point 4):
- From Rs. 3,25,00,000/- (Rupees Three Crore Twenty-Five Lakh Only) divided into 32,50,000 (Thirty-Two Lakh Fifty Thousand) equity shares of face value of Rs. 10/- each
- To Rs. 4,00,00,000/- (Rupees Four Crore Only) divided into 40,00,000 (Forty Lakh) equity shares of face value of Rs. 10/- each
This will require a consequent alteration of the Capital Clause of the Memorandum of Association, subject to shareholder approval.
Shareholder meeting and timetable
To seek member approval for these capital-related items, the board has decided to convene an Extra-Ordinary General Meeting (EOGM) (board's outcome letter, point 5):
- Date of EOGM: December 14, 2026
- Day: Monday
- Time: 1.00 P.M.
The notice of the EOGM will be submitted in due course. The filing does not state any record date or ex-date for the warrants issue; eligibility will be determined as per the terms to be set out in the EOGM notice and subsequent allotment process.
Other board decisions
The same meeting also approved the unaudited standalone and consolidated financial results for the half year ended September 30, 2026, along with the limited review reports (board's outcome letter, points 1 and 2; see the statement of financial results and accompanying auditor review reports on pages 8–18).
The board recorded the resignation of Mr. Avijit Mallick (DIN: 08438911) as Independent Director with effect from November 14, 2026, and his cessation as Chairperson of the Audit Committee, Nomination and Remuneration Committee and Stakeholders’ Relationship Committee (board's outcome letter, point 6; Annexure B and Annexure D). It also appointed Mrs. Nikita Jain (DIN: 08222385) as an Additional Director designated as an Independent Director with effect from November 14, 2026, subject to shareholder approval, and reconstituted the key board committees accordingly (board's outcome letter, point 7; Annexure B and Annexure C).
The board meeting commenced at 3.00 PM and concluded at 3.20 PM (board's outcome letter).
Track Euphoria Infotech (India) Ltd
Cruxal reads every Euphoria Infotech (India) Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Get every filing that moves a stock
One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.
Cruxal publishes market coverage for information only. Nothing here is investment advice.